A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity
JR Garlich, P De, N Dey, JD Su, X Peng, A Miller… - Cancer …, 2008 - aacrjournals.org
PTEN and the pan phosphoinositide 3-kinase (PI3K) inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1benzopyran-4-one
(LY294002) exert significant control over tumor-induced angiogenesis …
(LY294002) exert significant control over tumor-induced angiogenesis …
RAC1 takes the lead in solid tumors
P De, JC Aske, N Dey - Cells, 2019 - mdpi.com
Three GTPases, RAC, RHO, and Cdc42, play essential roles in coordinating many cellular
functions during embryonic development, both in healthy cells and in disease conditions like …
functions during embryonic development, both in healthy cells and in disease conditions like …
Wnt signaling in triple negative breast cancer is associated with metastasis
N Dey, BG Barwick, CS Moreno, M Ordanic-Kodani… - BMC cancer, 2013 - Springer
Background Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the
basal-like subtype (with limited discordance) is an aggressive form of the disease which …
basal-like subtype (with limited discordance) is an aggressive form of the disease which …
The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies
J Kreutzfeldt, B Rozeboom, N Dey… - American journal of …, 2020 - pmc.ncbi.nlm.nih.gov
Human Epidermal Growth Factor Receptor 2-positive breast cancer (HER2+ BC) is defined
by increased amplification of the ERBB2/neu oncogene and/or overexpression of its …
by increased amplification of the ERBB2/neu oncogene and/or overexpression of its …
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
N Dey, P De, B Leyland-Jones - Pharmacology & therapeutics, 2017 - Elsevier
Breast cancer (BC) is the most common women cancer and second most common cause of
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …
The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration
N Dey, HE Crosswell, P De, R Parsons, Q Peng… - Cancer …, 2008 - aacrjournals.org
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is mutated or lost
in 60% to 70% of advanced gliomas and is associated with malignant phenotypic changes …
in 60% to 70% of advanced gliomas and is associated with malignant phenotypic changes …
Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner
Mutations of genes in tumor cells of Triple Negative subset of Breast Cancer (TNBC) deregulate
pathways of signal transduction. The loss of tumor suppressor gene PTEN is the most …
pathways of signal transduction. The loss of tumor suppressor gene PTEN is the most …
ER+ metastatic breast cancer: Past, present, and a prescription for an apoptosis-targeted future
B Rozeboom, N Dey, P De - American journal of cancer …, 2019 - pmc.ncbi.nlm.nih.gov
The importance and role of the estrogen receptor (ER) pathway have been well-recognized
in both breast cancer development and progression. The treatment of choice in women with …
in both breast cancer development and progression. The treatment of choice in women with …
Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness
…, JH Carlson, LS Friedman, BR Leyland-Jones, N Dey - Neoplasia, 2014 - Elsevier
Phosphoinositide 3-kinase (PI3K) pathway, in addition to its pro-proliferative and antiapoptotic
effects on tumor cells, contributes to DNA damage repair (DDR). We hypothesized that …
effects on tumor cells, contributes to DNA damage repair (DDR). We hypothesized that …
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors
N Dey, P De, LJ Brian - American journal of translational …, 2015 - pmc.ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF) dependent tumor angiogenesis is an essential
step for the initiation and promotion of tumor progression. The hypothesis that VEGF-driven …
step for the initiation and promotion of tumor progression. The hypothesis that VEGF-driven …